InspireMD, Inc. announced the commercial launch of the CGuard Prime carotid stent system in the United States. On June 24, the comp ...

InspireMD announced today that it launched its CGuard Prime carotid stent after receiving FDA premarket approval (PMA).

InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard Prime carotid stent system for the prevention of stroke, today announced the official commercial launch of the CGuard Prime carotid stent system ...

In this randomized trial, the use of cerebral embolic protection (CEP) did not decrease the 72-hour incidence of stroke in ...

The characteristics of combat trauma to blood vessels include deep and widespread damage to the vascular wall, often ...

Natural products industry companies share overviews on the latest science on their dietary supplement branded ingredients and ...

InspireMD, Inc. (the "Company") (Nasdaq: NSPR), developer of the CGuard Prime Carotid Stent System for the prevention of stroke, today announced that the U.S.

Using data from the Rotterdam Study in the Netherlands, researchers have uncovered that carotid artery plaques can undergo potentially dangerous changes over time in patients without symptoms, ...

They found that among 1,630 participants with carotid artery thickening and white-matter hyperintensities on MRI scans, arterial plaque correlated with white-matter damage, even after accounting for ...

The target lesion was in the internal carotid artery (ICA) alone in about 80% of cases; the remaining cases represented the ICA plus common carotid artery.

Your arteries play an important role in your cardiovascular health, transporting blood from the heart to all of the body's cells. And that's especially true for your carotid (neck) arteries, since ...

PSVs and end-diastolic velocities of the ICA and common carotid artery were recorded. Patients with PSVs of the ICA of > 140 cm/s underwent carotid computed tomographic (CT) angiography.